GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Societal CDMO Inc (NAS:SCTL) » Definitions » Cyclically Adjusted PB Ratio

Societal CDMO (Societal CDMO) Cyclically Adjusted PB Ratio : 0.67 (As of Apr. 28, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Societal CDMO Cyclically Adjusted PB Ratio?

As of today (2024-04-28), Societal CDMO's current share price is $1.10. Societal CDMO's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $1.65. Societal CDMO's Cyclically Adjusted PB Ratio for today is 0.67.

The historical rank and industry rank for Societal CDMO's Cyclically Adjusted PB Ratio or its related term are showing as below:

SCTL' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.2   Med: 0.31   Max: 0.76
Current: 0.67

During the past years, Societal CDMO's highest Cyclically Adjusted PB Ratio was 0.76. The lowest was 0.20. And the median was 0.31.

SCTL's Cyclically Adjusted PB Ratio is ranked better than
80.06% of 647 companies
in the Drug Manufacturers industry
Industry Median: 1.75 vs SCTL: 0.67

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Societal CDMO's adjusted book value per share data for the three months ended in Dec. 2023 was $0.559. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $1.65 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Societal CDMO Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Societal CDMO's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Societal CDMO Cyclically Adjusted PB Ratio Chart

Societal CDMO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.21

Societal CDMO Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.76 0.30 0.21

Competitive Comparison of Societal CDMO's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Societal CDMO's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Societal CDMO's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Societal CDMO's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Societal CDMO's Cyclically Adjusted PB Ratio falls into.



Societal CDMO Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Societal CDMO's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.10/1.65
=0.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Societal CDMO's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Societal CDMO's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.559/129.4194*129.4194
=0.559

Current CPI (Dec. 2023) = 129.4194.

Societal CDMO Quarterly Data

Book Value per Share CPI Adj_Book
201403 3.815 99.695 4.952
201406 3.473 100.560 4.470
201409 2.881 100.428 3.713
201412 2.456 99.070 3.208
201503 1.962 99.621 2.549
201506 1.878 100.684 2.414
201509 3.076 100.392 3.965
201512 4.374 99.792 5.673
201603 3.761 100.470 4.845
201606 3.172 101.688 4.037
201609 3.425 101.861 4.352
201612 3.761 101.863 4.778
201703 3.378 102.862 4.250
201706 2.991 103.349 3.745
201709 2.605 104.136 3.237
201712 1.508 104.011 1.876
201803 1.257 105.290 1.545
201806 1.182 106.317 1.439
201809 0.654 106.507 0.795
201812 -0.894 105.998 -1.092
201903 -0.860 107.251 -1.038
201906 -0.835 108.070 -1.000
201909 -0.879 108.329 -1.050
201912 -0.288 108.420 -0.344
202003 -0.520 108.902 -0.618
202006 -0.652 108.767 -0.776
202009 -0.640 109.815 -0.754
202012 -0.493 109.897 -0.581
202103 -0.281 111.754 -0.325
202106 0.568 114.631 0.641
202109 0.954 115.734 1.067
202112 0.901 117.630 0.991
202203 0.693 121.301 0.739
202206 0.659 125.017 0.682
202209 0.622 125.227 0.643
202212 0.656 125.222 0.678
202303 0.608 127.348 0.618
202306 0.603 128.729 0.606
202309 0.556 129.860 0.554
202312 0.559 129.419 0.559

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Societal CDMO  (NAS:SCTL) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Societal CDMO Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Societal CDMO's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Societal CDMO (Societal CDMO) Business Description

Traded in Other Exchanges
N/A
Address
1 E. Uwchlan Avenue, Suite 112, Exton, PA, USA, 19341
Societal CDMO Inc is a bi-coastal contract development and manufacturing organization. It offers capabilities spanning pre-Investigational New Drug development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms primarily focused on small molecules. The company also provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging, and logistics services to the global pharmaceutical market.
Executives
Bryan M. Reasons director C/O IMPAX LABORATORIES, INC., 30831 HUNTWOOD AVENUE, HAYWARD CA 94544
Elena Cant director C/O SOCIETAL CDMO, INC., 1 E. UWCHLAN AVENUE, SUITE 112, EXTON PA 19341
Enloe J David Jr director, officer: Chief Executive Officer
James Charles Miller director 490 LAPP ROAD, MALVERN PA 19355
Wayne Weisman director 490 LAPP ROAD, MALVERN PA 19355
William Ashton director C/O HARRISON CONSULTING GROUP, PO BOX 283, NEWTOWN SQUARE PA 19073
Winston J Churchill director C/O SCP PARTNERS, SUITE 300, 1200 LIBERTY RIDGE DRIVE, WAYNE PA 19087
Awm Investment Company, Inc. 10 percent owner 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022
Mathew Paul Arens director, 10 percent owner C/O FIRST LIGHT ASSET MANAGEMENT, LLC, 3300 EDINBOROUGH WAY, SUITE 201, EDINA MN 55435
First Light Asset Management, Llc director, 10 percent owner 3300 EDINBOROUGH WAY, SUITE 201, EDINA MN 55435
Laura L. Parks director C/O RECRO PHARMA, INC., 490 LAPP ROAD, MALVERN PA 29355
Michael Berelowitz director 415 EAST 37TH STREET, APT 36C, NEW YORK NY 10016
Ryan David Lake officer: Chief Financial Officer KENSEY NASH CORPORATION, 735 PENNSYLVANIA DRIVE, EXTON PA 19341
Scp Vitalife Partners (israel) Ii, L.p. 10 percent owner SUITE 190, 7 GREAT VALLEY PARKWAY, MALVERN PA 19355
Scp Vitalife Partners Ii Lp 10 percent owner SUITE 190, 7 GREAT VALLEY PARKWAY, MALVERN PA 19355